Zions Bancorporation N.A. Has $1.48 Million Stock Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Zions Bancorporation N.A. boosted its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 29.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,017 shares of the company's stock after purchasing an additional 15,555 shares during the period. Zions Bancorporation N.A.'s holdings in Stevanato Group were worth $1,482,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Natixis Advisors LLC raised its stake in shares of Stevanato Group by 20.3% during the 3rd quarter. Natixis Advisors LLC now owns 51,343 shares of the company's stock worth $1,027,000 after purchasing an additional 8,669 shares in the last quarter. Raymond James Trust N.A. raised its position in Stevanato Group by 22.6% during the third quarter. Raymond James Trust N.A. now owns 12,556 shares of the company's stock worth $251,000 after acquiring an additional 2,317 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in Stevanato Group by 16.9% in the third quarter. The Manufacturers Life Insurance Company now owns 294,235 shares of the company's stock valued at $5,885,000 after acquiring an additional 42,629 shares during the last quarter. Hardy Reed LLC grew its position in shares of Stevanato Group by 8.2% in the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company's stock valued at $222,000 after acquiring an additional 840 shares during the period. Finally, Glenmede Trust Co. NA increased its stake in shares of Stevanato Group by 12.7% during the 3rd quarter. Glenmede Trust Co. NA now owns 35,941 shares of the company's stock worth $719,000 after purchasing an additional 4,050 shares during the last quarter.

Remove Ads

Stevanato Group Price Performance

Shares of STVN stock traded down €0.07 ($0.08) during trading on Friday, hitting €20.25 ($22.01). The company had a trading volume of 209,100 shares, compared to its average volume of 347,647. The stock's 50-day moving average price is €20.90 and its 200 day moving average price is €20.59. Stevanato Group S.p.A. has a one year low of €16.56 ($18.00) and a one year high of €32.98 ($35.85). The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The firm has a market capitalization of $6.13 billion, a P/E ratio of 43.09, a price-to-earnings-growth ratio of 7.18 and a beta of 0.60.

Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, hitting analysts' consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company had revenue of €352.68 million for the quarter, compared to analysts' expectations of €346.26 million. Equities analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Morgan Stanley reiterated an "equal weight" rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. William Blair reissued an "outperform" rating on shares of Stevanato Group in a report on Friday, March 7th. Bank of America raised their price target on Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a report on Friday, December 13th. UBS Group decreased their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a report on Friday, March 7th. Finally, Wolfe Research assumed coverage on shares of Stevanato Group in a research note on Friday, December 13th. They set an "outperform" rating and a $28.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of €25.70 ($27.93).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.